{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:54:33Z","timestamp":1793451273656,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400396"],"award-info":[{"award-number":["82400396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZCLMS26H1501"],"award-info":[{"award-number":["ZCLMS26H1501"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bbadis.2026.168476","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:18:40Z","timestamp":1790291920000},"page":"168476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PARP7 drives angiotensin II-induced vascular remodeling via ADP-ribosylation and inhibition of GPX4"],"prefix":"10.1016","volume":"1873","author":[{"given":"Liming","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenliang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.bbadis.2026.168476_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/CS20220797","article-title":"Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation","volume":"138","author":"Toton-Zuranska","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168476_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31200","article-title":"Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection","volume":"239","author":"Elmarasi","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","article-title":"Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0020","doi-asserted-by":"crossref","first-page":"C183","DOI":"10.1152\/ajpcell.00074.2022","article-title":"Arterial remodeling: the role of mitochondrial metabolism in vascular smooth muscle cells","volume":"324","author":"Qin","year":"2023","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41392-023-01577-3","article-title":"NAD(+) exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168476_bb0030","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1089\/ars.2017.7445","article-title":"NAD(+) deficiency is a common central pathological factor of a number of diseases and aging: mechanisms and therapeutic implications","volume":"30","author":"Zhang","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2026.168476_bb0035","article-title":"Functional roles of ADP-ribosylation writers, readers and erasers","volume":"10","author":"Li","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168476_bb0040","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.cell.2023.08.030","article-title":"ADP-ribosylation from molecular mechanisms to therapeutic implications","volume":"186","author":"Suskiewicz","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168476_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12849","article-title":"PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation","volume":"7","author":"Iwata","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168476_bb0050","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/ATVBAHA.124.321682","article-title":"PARylation of POLG mediated by PARP1 accelerates Ferroptosis-induced vascular calcification via activating Adora2a\/Rap1 signaling","volume":"45","author":"Yang","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.bbadis.2026.168476_bb0055","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1038\/s44318-025-00545-7","article-title":"PARP7 is a proteotoxic stress sensor that labels proteins for degradation","volume":"44","author":"Ikenga","year":"2025","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168476_bb0060","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241184","article-title":"PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease","volume":"222","author":"Jeltema","year":"2025","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168476_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70013","article-title":"PARP7i clinical candidate RBN-2397 exerts antiviral activity by modulating interferon-beta associated innate immune response in macrophages","volume":"85","author":"Du","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s43556-025-00385-1","article-title":"PARPs and PARP inhibitors: molecular mechanisms and clinical applications","volume":"6","author":"Wang","year":"2025","journal-title":"Mol Biomed"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168476_bb0075","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/HYPERTENSIONAHA.122.20004","article-title":"GSDMD (Gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification Cascade via mitochondria-STING (stimulator of interferon genes) Axis","volume":"79","author":"Han","year":"2022","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168476_bb0080","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.118.11860","article-title":"Angiotensin II causes biphasic STAT3 activation through TLR4 to initiate cardiac remodeling","volume":"72","author":"Han","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2026.168476_bb0085","article-title":"Ferroptosis: a potential target in cardiovascular disease","volume":"9","author":"Leng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168476_bb0090","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0095","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/s41467-024-45823-w","article-title":"Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168476_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2024.05.036","article-title":"Neutrophil extracellular trap-induced ferroptosis promotes abdominal aortic aneurysm formation via SLC25A11-mediated depletion of mitochondrial glutathione","volume":"221","author":"Qi","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2026.168476_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168476_bb0110","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1158\/2159-8290.CD-23-1220","article-title":"BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers","volume":"14","author":"Lei","year":"2024","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168476_bb0115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tem.2024.09.003","article-title":"Targeting ACSLs to modulate ferroptosis and cancer immunity","volume":"36","author":"Lin","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168476_bb0120","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s44321-025-00214-6","article-title":"PARP7 as a new target for activating anti-tumor immunity in cancer","volume":"17","author":"Popova","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168476_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2025.103873","article-title":"Multiple functions of PARP1 in the repair of DNA double strand breaks","volume":"152","author":"Ortega","year":"2025","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbadis.2026.168476_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2024.103690","article-title":"The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication","volume":"140","author":"Zhang","year":"2024","journal-title":"DNA Repair (Amst)"},{"issue":"9","key":"10.1016\/j.bbadis.2026.168476_bb0135","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/2012.jama.10503","article-title":"Aortic stiffness, blood pressure progression, and incident hypertension","volume":"308","author":"Kaess","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168476_bb0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.122.20601","article-title":"Angiotensin II type 1A receptor expressed in smooth muscle cells is required for hypertensive vascular remodeling in mice infused with angiotensin II","volume":"80","author":"Okuno","year":"2023","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.bbadis.2026.168476_bb0145","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1038\/s44318-025-00510-4","article-title":"Parp7 generates an ADP-ribosyl degron that controls negative feedback of androgen signaling","volume":"44","author":"Wierbilowicz","year":"2025","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s44318-025-00656-1","article-title":"Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation","volume":"45","author":"Gorelik","year":"2026","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168476_bb0155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1074\/mcp.TIR119.001315","article-title":"An advanced strategy for comprehensive profiling of ADP-ribosylation sites using mass spectrometry-based proteomics","volume":"18","author":"Hendriks","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbadis.2026.168476_bb0160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60480","article-title":"Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets","volume":"10","author":"Rodriguez","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168476_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/jasms.0c00040","article-title":"Gas-phase fragmentation of ADP-Ribosylated peptides: arginine-specific side-chain losses and their implication in database searches","volume":"32","author":"Gehrig","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168476_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mas.21811","article-title":"Uncommon posttranslational modifications in proteomics: ADP-ribosylation, tyrosine nitration, and tyrosine sulfation","volume":"43","author":"Bashyal","year":"2024","journal-title":"Mass Spectrom. Rev."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600342X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600342X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:43:31Z","timestamp":1791575011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392600342X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2027,2]]}},"alternative-id":["S092544392600342X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168476","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP7 drives angiotensin II-induced vascular remodeling via ADP-ribosylation and inhibition of GPX4","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168476"}}